- Filed
- Nov 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 14, 2024 | 1.32M sh |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $3.72M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $1.05M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $2.95M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $5.76M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $4.59M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $7.83M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $4.32M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $1.54M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $7.92M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $6.3M |
| Shares Diluted restated | Q3 2024 · Sep 30, 2023 | 4.73K sh |
| Shares Diluted restated | Q3 2024 · Sep 30, 2023 | 3.55K sh |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$7.33M |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | −$2.91M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | −$2.79M |
| Stockholders Equity restated | Q3 2024 · Dec 31, 2022 | $899.3K |
| Eps Diluted restated | Q3 2024 · Sep 30, 2023 | −$404.00 |
| Eps Diluted restated | Q3 2024 · Sep 30, 2023 | −$6,640.00 |
| Eps Basic restated | Q3 2024 · Sep 30, 2023 | −$404.00 |
| Eps Basic restated | Q3 2024 · Sep 30, 2023 | −$6,640.00 |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $1.41M |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $4.18M |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $344.94K |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $2.83M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$1.91M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$11.91M |
| Net Income | Q3 2024 · Jun 30, 2023 | −$10M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$2.38M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$10.55M |
| Revenue | Q3 2024 · Sep 30, 2023 | $229.95K |
| Revenue | Q3 2024 · Sep 30, 2023 | $455.48K |